At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Poly-L-Lactic Acid (Sculptra) injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Emotional and Functional Benefits of Poly-L-Lactic Acid
In Brief
A clinical study evaluating Poly-L-Lactic Acid (Sculptra) injection for Facial Volume Loss. Completed, enrolled 50 participants.
Detailed Summary
This study will evaluates the emotional and functional benefits of Poly-L-Lactic Acid (Sculptra™), a cosmetic product used to fill defects of the skin. All participants will receive Sculptra™.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFacial Volume Loss
Countries--
CollaboratorsGalderma R&D
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedNov 2015
Primary CompletionJun 2017
Study CompletionAug 2017
TodayJul 2026
First PostedNov 24, 2015
Enrollment StartNov 1, 2015
Primary CompletionJun 1, 2017
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.6 years ago
Interventions
Poly-L-Lactic Acid (Sculptra) injectiondrug
1 vial of of poly-l-lactic acid (Sculptra) reconstituted in the usual sterile fashion with 7cc of sterile water and 2cc of Lidocaine without epinephrine. The contents of the vial will be injected as deemed appropriate by the certified injector and agreed upon by the study subject.